These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38413109)
1. Evaluation of Malignancy Risk of Ampullary Tumors Detected by Endoscopy Using 2-[ Chuang PJ; Wang HP; Tien YW; Chin WS; Hsieh MS; Chen CC; Hong TC; Ko CL; Wu YW; Cheng MF Korean J Radiol; 2024 Mar; 25(3):243-256. PubMed ID: 38413109 [TBL] [Abstract][Full Text] [Related]
2. Benefits of Wen G; Gu J; Zhou W; Wang L; Tian Y; Dong Y; Fu L; Wu H Eur Radiol; 2020 Sep; 30(9):5089-5098. PubMed ID: 32346795 [TBL] [Abstract][Full Text] [Related]
3. Preoperative 2-[ Chuang PJ; Wang HP; Lin YJ; Chen CC; Tien YW; Hsieh MS; Yang SH; Yen RF; Ko CL; Wu YW; Cheng MF Eur Radiol; 2021 Oct; 31(10):8040-8049. PubMed ID: 33864503 [TBL] [Abstract][Full Text] [Related]
4. FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis. Watanabe A; Harimoto N; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Hirai K; Tanaka H; Mochida Y; Kogure N; Higuchi T; Shirabe K J Surg Oncol; 2021 Sep; 124(3):317-323. PubMed ID: 33978237 [TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of metabolic activity detected by pre-operative 18F FDG PET/CT in ampullary adenocarcinoma. Park YM; Seo HI Medicine (Baltimore); 2021 Oct; 100(42):e27561. PubMed ID: 34678895 [TBL] [Abstract][Full Text] [Related]
7. Role of Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of PET/CT for the differentiation and characterization of periampullary lesions. Cheng MF; Wang HP; Tien YW; Liu KL; Yen RF; Tzen KY; Wu YW Clin Nucl Med; 2013 Sep; 38(9):703-8. PubMed ID: 23816944 [TBL] [Abstract][Full Text] [Related]
10. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Shin DS; Shon OJ; Byun SJ; Choi JH; Chun KA; Cho IH Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481 [TBL] [Abstract][Full Text] [Related]
11. Differentiating between benign and malignant ampullary strictures: a prediction model using a nomogram based on CT imaging and clinical findings. Lee JE; Choi SY; Lee MH; Lim S; Min JH; Hwang JA; Lee S; Kim JH Eur Radiol; 2022 Nov; 32(11):7566-7577. PubMed ID: 35585200 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG activitiy PET/CT and CA-19.9 levels for the prediction of histopathological features and localization of peri- ampullary tumors. Akcam AT; Ülkü A; Rencuzoğulları A; Parsak CK; Yapar Z; Doran F; Demiryürek H; Okoh AK Turk J Gastroenterol; 2015 Mar; 26(2):170-5. PubMed ID: 25835117 [TBL] [Abstract][Full Text] [Related]
14. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology. Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma. Li S; Liu J; Wang G; Feng L; Yang X; Kan Y; Wang W; Yang J Eur J Radiol; 2024 Jan; 170():111243. PubMed ID: 38043380 [TBL] [Abstract][Full Text] [Related]
16. The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions. Sa R; Zhao HG; Dai YY; Guan F Medicine (Baltimore); 2018 Sep; 97(38):e12521. PubMed ID: 30235771 [TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. Sperti C; Pasquali C; Fiore V; Bissoli S; Chierichetti F; Liessi G; Pedrazzoli S Am J Surg; 2006 Jun; 191(6):743-8. PubMed ID: 16720142 [TBL] [Abstract][Full Text] [Related]
18. Delayed Yan H; Zhou X; Wang X; Li R; Shi Y; Xia Q; Wan L; Huang G; Liu J Radiology; 2019 Oct; 293(1):144-150. PubMed ID: 31407969 [TBL] [Abstract][Full Text] [Related]
19. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors. Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363 [TBL] [Abstract][Full Text] [Related]
20. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]